RAB6D

Across TCGA pan-cancer cohorts, RAB6D Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RAB6D data layer compared with 24 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RAB6D Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RAB6D expression acts as an unfavorable survival marker.

COAD are the cancer types where RAB6D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.157	0.871	<.001	27	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RAB6D–COAD (OS)

Open the COAD breakdown →